Overview
- The Advisory Committee on Immunization Practices (ACIP) resumed its meetings after a nearly two-month delay caused by administrative changes under HHS Secretary Robert F. Kennedy Jr.
- The committee is deliberating a shift from universal COVID-19 booster recommendations to a risk-based approach targeting high-risk groups for the 2025–2026 season.
- A proposal to lower the recommended age for RSV vaccination to adults 50 and older is under review to better protect vulnerable populations from severe complications.
- Delays in ACIP meetings have raised concerns about the Vaccines for Children program, potentially jeopardizing free flu shots for children this fall.
- Operational disruptions at the CDC, including staffing cuts and technical issues, have highlighted challenges in maintaining effective public health communication and resources.